Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of a biological therapy for metastatic melanoma or metastatic kidney cancer has completed its status/enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer, Melanoma (Skin) | Phase 1 | Status: COMPLETED